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Background: Rapid diagnostic tests (RDTs) for malaria provide a practical alternative to light microscopy for malaria
diagnosis in resource-limited settings. Three-band RDTs incorporating two parasite antigens may have enhanced
diagnostic specificity, relative to two-band RDTs with a single parasite antigen (typically histidine-rich protein 2
[HRP2]).
Methods: Phase 1: 2,000 children, two months to five years of age, admitted to a referral hospital in Jinja, Uganda,
with acute febrile illness were enrolled. A WHO highly rated three-band RDT was compared to light microscopy of
thick peripheral blood films read by local expert microscopists.
Phase 2: the three-band RDT was used as a screening tool for inclusion of patients in a clinical trial, and subjects
with three positive RDT bands were tested by microscopy using blood samples drawn in parallel. Discordant results
were adjudicated by PCR.
Results: Phase 1: 1,648 children had both a RDT and peripheral blood smear performed. The specificity of a RDT
with all three bands positive was 82% (95% CI: 79-85%) compared to 62% (95% CI: 59-66%) for HRP2 alone. The
sensitivity was 88% (95% CI: 85-89%) and 94% (95% CI: 92-95%) for three-band positive RDT and HRP2 antigen,
respectively. 119 patients (7.2%) had a positive HRP2 band, but negative parasite lactate dehydrogenase (pLHD)
band and negative peripheral smear, and 72 (61%) of these had received pre-treatment with anti-malarials,
suggesting a false positive HRP2 result (p = 0.002).
Phase 2: the positive predictive value (PPV) of the three-band RDT was 94% (95% CI 89%-97%) using microscopy as
the reference standard. However, microscopy-discordant results were shown to be positive for P. falciparum by PCR
in all cases, suggesting that the PPV was in fact higher.
Conclusion: The pLDH antigen on three-band RDTs, used in combination with HRP2, provides added diagnostic
specificity for malaria parasitaemia and may be useful to distinguish acute infection from recently treated infection.
In situations where diagnostic specificity is desirable (e.g., for selection of malaria-infected participants in clinical
trials), a three-band RDT should be considered in a sub-Saharan African setting.
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Immunochromatographic rapid diagnostic tests (RDTs) are
practical and accurate tools to guide case management of
clinical malaria, particularly in resource-constrained set-
tings where routine microscopy is absent or of poor quality.
In addition to their clinical utility, RDTs have been used for
epidemiologic surveillance [1,2], and for selection of pa-
tients for clinical trials of new therapies [3,4]. The test per-
formance characteristics of RDTs have been described in
numerous reports from Asia and Africa for the purpose of
malaria case management, where high sensitivity is desir-
able in order to avoid false negative results that could lead
to inappropriately withholding treatment from patients
with malaria [5,6]. In other applications, such as selection
of patients for clinical trials, test specificity may be para-
mount, in order to avoid false positive tests which would
lead to inappropriate inclusion of patients without malaria.
The test principle underlying malaria RDTs is the detec-
tion of parasite antigens, most commonly histidine-rich
protein 2 (HRP2), parasite lactate dehydrogenase (pLDH),
and/or parasite aldolase through lateral flow immunochro-
matography. Whereas HRP2 is specific to Plasmodium fal-
ciparum, pLDH and parasite aldolase are common to all
Plasmodium species. Test cartridges or strips may incorp-
orate two bands (e.g., HRP2 and a control band), or three
bands (e.g., HRP2, pLDH, and a control band). The use of
three-band RDTs allows the distinction of P. falciparum
from Plasmodium vivax in settings, such as Asia and South
America, where both species co-circulate [7]. On the other
hand, in sub-Saharan Africa, the predominant pathogen is
P. falciparum, and two-band RDTs incorporating HRP2
antigen as the sole antigen are sensitive tests for malaria
diagnosis in clinical practice [8]. One well-recognized limi-
tation of two-band RDTs is the occurrence of false-positive
results caused by persistent HRP2 antigenaemia after effect-
ive anti-malarial treatment [9,10]. In epidemiologic surveil-
lance, this may result in over-estimation of the true parasite
prevalence by 1.5 to 7.9% [11,12]. For recruitment of partic-
ipants into clinical trials of new treatments, highly specific
diagnosis with rapid turn-around time is desirable in order
to accurately identify participants that may benefit from the
experimental therapy while minimizing enrolment of unin-
fected participants, who may be unnecessarily exposed to
study risks and contaminate study analyses.
The objective of this study was to examine whether a
three-band RDT, combining both HPR2 and pLDH anti-
gens, would have increased diagnostic specificity for the
diagnosis of P. falciparum in an African context. Test per-
formance characteristics of this three-band RDT were ex-
amined in a large cohort of children hospitalized with
febrile illness in Africa. Furthermore, this approach was
validated using the three-band RDT as a screening tool for
patient inclusion in a randomized controlled trial of a
novel adjunctive treatment for severe malaria [13].Methods
This study involved two phases: the first was a prospective
cross-sectional comparison of a three band RDT with mi-
croscopy for the diagnosis of P. falciparum and the second
was validation of the three-band RDT for recruitment of
patients with falciparum malaria in the context of a ran-
domized clinical trial [13]. The commercially available RDT
used in both phases of this study (First Response Malaria
Ag. (pLDH/HRP2) Combo Rapid Diagnostic Test, Premier
Medical Corporation Limited, India) is the highest-ranked
assay by a standardized WHO testing methodology [14].
Previous reports of its use in India [7] and Yemen [15] sup-
port its high sensitivity and specificity.
For the first phase, febrile children presenting to Jinja
Regional Referral Hospital, Uganda, were enrolled. Inclu-
sion criteria were: age 2 months to 5 years; parental report
of fever within the past 48 hours or axillary temperature
higher than 37.5°C; and hospitalization indicated based on
the admitting physician’s judgment. Patients were ex-
cluded if the accompanying parent or guardian did not
provide written informed consent. Demographic and clin-
ical information was collected, and a peripheral blood
sample was drawn for testing by both RDT and micros-
copy. Study personnel consisting of experienced paediatric
nurses and medical officers, were trained in the safe use
and interpretation of the RDT from a small volume
(15 μL) of capillary or venous blood. A simultaneously col-
lected EDTA-anticoagulated sample was spread as a
thick smear on a glass slide, dried, stained with Field’s
stain, and examined by an experienced technician using
a light microscope using a single reading at the Jinja
Regional Referral Hospital (paediatric campus). The
clinical personnel were not aware of the microscopy re-
sult at the time of RDT interpretation, and technician per-
forming the microscopy was not aware of the RDT result.
Test performance characteristics (sensitivity, specificity,
positive predictive value, negative predictive value) of the
RDT were computed, using microscopy as the reference
standard. A sample size calculation using standard formu-
lae for the confidence interval on a proportion (assuming
sensitivity = specificity = 90%, and disease prevalence in the
screened population = 60%) indicated that approximately
1,400 patients would be required to estimate both the sensi-
tivity and specificity within a range of 5% at α = 0.05 level
of significance.
For the second phase, patients with suspected severe
malaria were screened from the emergency department
at Jinja Regional Referral Hospital, and 180 patients
were finally recruited for a randomized controlled trial
of a novel adjunctive treatment for severe malaria (nitric
oxide). The hypothesis, rationale, and design of the trial,
together with inclusion and exclusion criteria are de-
scribed in detail elsewhere [13,16]. The same three-
band RDT (First Response Combo pLDH/HRP2) was
Table 1 Test performance characteristics of RDT bands
among febrile hospitalized children (n = 1648) when
compared to microscopy1
Sensitivity Specificity PPV NPV
HRP2 94 (92–95) 62 (59–66) 81 (78–83) 86 (82–89)
pLDH 88 (86–90) 80 (77–83) 88 (86–90) 80 (77–83)
3-bands2 88 (85–89) 82 (78–84) 89 (87–91) 80 (76–83)
1Numbers of patients within each possible subset of diagnostic test result
combinations were as follows: HRP2+, pLDH+, microscopy + 902; HRP2+, pLDH+,
microscopy- 113; HRP2+, pLDH-, microscopy + 65; HRP2-, pLDH+, microscopy + 7;
HRP2+, pLDH-, microscopy- 119; HRP2-, pLDH+, microscopy- 11; HRP2-, pLDH-,
microscopy + 57; HRP2-, pLDH-, microscopy- 374.
2Both the HRP2 and pLDH bands (as well as control band) positive.
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arum malaria, and patients were enrolled only if all three
bands were positive (i.e., positive HRP2 and pLDH antige-
naemia, as well as control band). Trial participants had
Giemsa-stained peripheral blood smears (thin and thick)
assessed for quantitative malaria parasite density by light
microscopy at a College of American Pathologists (CAP)
certified, quality-controlled central research laboratory, the
Makerere University-John’s Hopkins University (MU-JHU)
Core Lab. The positive predictive value of the RDT in this
context was calculated, and discordant results (RDT posi-
tive, microscopy negative) were examined in further detail.
A multiplex polymerase chain reaction (PCR) assay was
used to adjudicate discordant results, using methods de-
scribed previously [17-19].
The accompanying parent or caregiver of all paediat-
ric patients in this study provided full, written, informed
consent for participation. Ethical oversight was provided
by the Makerere University in Kampala, Uganda and the
University Health Network, in Toronto, Canada. The study
was conducted in accordance with the declaration of
Helsinki and following Good Clinical Practice guidelines.
Results
For the first phase of the study, 2,000 febrile children were
prospectively enrolled from the Emergency Department of
the Jinja Regional Referral Hospital, from 15 February
2012 to 11 April 2013. The median (IQR) age was 1.3
(0.75-2.1) years and 886 (45%) were female. Common clin-
ical diagnoses at presentation were malaria, pneumonia,
sepsis, meningitis in 1518 (76%), 318 (16%), 220 (11%),
and 33 (1.7%) patients, respectively. 65 (3.3%) patients in
the cohort had a fatal outcome of their febrile illness.
1,646 children had both a RDT and peripheral blood
smear performed. The microscopy result was missing in
284 cases (14%) and the RDT result was missing in 83
(4.2%). Patients with missing data were similar in age and
gender to those with available results for both tests: age
(median (IQR) 1.4 (0.75-2.0) vs 1.3 (0.75-2.2), p = 0.77)
and gender (45% vs 44% female, p = 0.77). HRP2 antigen
was detected in 1199 (73%), pLDH in 1033 (63%), and
light microscopy was positive in 1031 (63%). Test per-
formance characteristics of the HRP2 line, the pLDH line
and the combination of both antigens is given in Table 1.
Of note, the specificity of a RDT with all three lines posi-
tive (HRP2, pLDH, and control) was 82% (95% CI: 79-
85%) compared to 62% (95% CI: 59-66%) for HRP2 alone.
119 patients (7.2%) had a positive HRP2 line, but nega-
tive pLDH and negative peripheral smear. Of these, 72
(61%, p = 0.002 relative to other test results) had received
pre-treatment with anti-malarials, suggesting that a signifi-
cant proportion were false positive HRP2 results. Treat-
ment with an anti-malarial agent prior to presentation was
common in the cohort (773 patients, 47%), and wasassociated with a negative microscopy result (p = 0.001), a
negative pLDH result (p < 0.001), but was not statistically
significantly associated with a negative HRP2 result (p =
0.09), consistent with persistence of HRP2 antigenaemia
in recently treated patients.
For phase 2 of the study, we used the three-band RDT
as a screening tool for enrolment of febrile children in a
clinical trial conducted at the same centre. 727 patients
were screened for eligibility and 180 were enrolled, all of
whom had a RDT result with all three lines positive. A
CAP quality-assured reference laboratory examined per-
ipheral blood films by light microscopy, and 169 were
found to be positive for P. falciparum by this method, giv-
ing a positive predictive value of 94% (95%CI 89%-97%).
Ten patients had all three RDT lines positive (i.e., HRP2
and pLDH antigenaemia), yet had no parasites visualized
on microscopy. One further patient with three positive lines
had a diagnosis of Plasmodium ovale based on morphologic
appearance of parasites under microscopic examination.
These samples were tested by PCR for Plasmodium species:
all were positive for P. falciparum, and none were positive
for other Plasmodium species. Further clinical details for
these 10 cases are provided in Table 2. Clinical characteris-
tics and laboratory parameters of these 10 patients were
consistent with severe malaria, and were not different from
the 169 trial participants who had both positive RDT and
microscopy. Taken together, these findings suggest that the
10 patients with discordant RDT and microscopy results
had severe malaria (false-negative microscopy result), rather
than a false-positive RDT result. The patient with P. ovale
read on blood smear who was positive for P. falciparum by
PCR also likely had severe malaria from P. falciparum and
not P. ovale.
Discussion
This study demonstrates that a three-band RDT improves
specificity for the diagnosis of falciparum malaria among
febrile children hospitalized at a referral hospital in sub-
Saharan Africa. The additional specificity provided by the
combination of HRP2 and pLDH antigen positivity over
HRP2 positivity alone likely relates to the persistence of
Table 2 Clinical and prognostic features of microscopy negative (N = 10) and microscopy positive (N = 169) patients
enrolled in clinical trial with all three bands positive on RDT1
Microscopy negative (N = 10) Microscopy positive (N = 169) P value
Parasite density (geometric mean, range) 0 17,700 (80–696,000) -
Duration of fever prior to presentation (days), median (IQR) 3.5 (2.0-6.0) 3.0 (2.0-4.0) 0.78
Prostration, n/N (%) 8/10 (80) 155/169 (92) 0.22
Coma, n/N (%) 5/10 (50) 101/169 (60) 0.74
Convulsions, n/N (%) 8/10 (80) 135/169 (80) 1.0
BCS, median (IQR) 3 (2–4) 2 (2–3) 0.33
Deep breathing, n/N (%) 2/10 (20) 84/169 (50) 0.10
LODS2, median (IQR) 2 (1–2) 2 (1.5-3) 0.067
pH <7.353, n/N (%) 2/9 (22) 40/137 (29) 1.0
Lactate > 5 mmol/L3, n/N (%) 2/10 (20) 57/161 (35) 0.50
Base deficit > 8 mmol/L3, n/N (%) 4/9 (44) 65/137 (47) 1.0
1One additional patient was diagnosed with P. ovale based on microscopy, but PCR identified P. falciparum mono-infection.
2Lambaréné Organ Dysfunction Score.
3pH < 7.35 [20], lactate > 5 mmol/L and base deficit > 8 mmol/L [21] (lactic acidosis) have been identified as markers of poor prognosis in severe malaria.
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This finding was validated in an independent cohort of
hospitalized febrile children, using the three-band RDT as
a rapid screening tool for a clinical trial, showing that this
diagnostic strategy has a high positive predictive value for
falciparum malaria.
The sensitivity and specificity of the HPR2 antigen for
P. falciparum infection in this study were 94% and 62%, re-
spectively. The high sensitivity is consistent with numerous
previous studies in various populations, including a meta-
analysis of patients screened for uncomplicated malaria
(sensitivity = 95%) [5], a systematic review of 48 studies in
endemic areas (sensitivity = 93%) [6], and a meta-analysis of
over 5,000 non-immune travellers (sensitivity = 95%) [22].
The poor specificity of the HRP2 antigen in this study con-
trasts with meta-analyses that pool findings from diverse
populations (specificity ranges from 95-100%) [5,6,22], but
is consistent with observations among febrile hospitalized
children in Uganda (specificity of 72% [23] and 85% [24])
and nearby malaria-endemic countries (specificity of 65% in
Tanzania [8]). In situations where there is a low probability
of recently treated malaria, such as non-immune travellers
and outbreak situations in areas of lower endemicity, the
specificity of the HRP2 antigen is high (94% to 100%)
[15,22].
Typically, three-band RDTs are used in areas where
P. falciparum and P. vivax co-circulate, such as Asia and
South America [7]. Beyond their ability to help differenti-
ate vivax from falciparum malaria, the combination of
dual antigens on a three-band RDT can point to recently
treated falciparum infection because HRP2 and pLDH
antigenaemia persists for different periods after eradica-
tion of viable parasites. In one report, 4-10% of pLDH
tests were still positive compared with 69.7% of the HRP2
tests two weeks after a successfully treated malaria episode[25]. Other studies showed that the mean duration of
HRP2 antigenaemia was 32 days [23], and that circulating
HRP2 persisted in 68% of patients at 7 days and in 27% at
28 days after treatment [10]. The combination of HRP2
positivity and pLDH negativity may point to recently
treated infection, consistent with our findings that a high
proportion of patients with this RDT result had received
pre-treatment with an anti-malarial agent.
Limitations of this study include the use of an imperfect
reference standard: light microscopy of stained peripheral
smears. This approach may have led to misclassification of
disease state, as illustrated by the second phase of this
study, where discordant results adjudicated by PCR
showed in all 11 cases that the RDT-based diagnosis (se-
vere falciparum malaria) was likely correct, and the mi-
croscopy result likely represented false negative results or
incorrect speciation. The first phase of the study employed
Field’s stain, which is quicker and less labor intensive than
the gold standard Giemsa stain, but has been associated
with lower diagnostic sensitivity [26]. Technologists were
well trained and experienced, but quality control measures
were not in place to test their accuracy and only a single
reading was performed. Incomplete testing by either the
reference standard or RDT could potentially create sam-
pling bias (1,648/2,000 = 82% patients were tested by both
modalities in parallel). The second (validation) phase in-
cluded only patients with positive three-band RDT result,
which allowed us to document the positive predictive
value of this diagnostic approach, but did not allow com-
putation of sensitivity, specificity and negative predictive
value. The patient population for both phases of the study
included children hospitalized for febrile illness in a mal-
aria hyper-endemic zone. While this is arguably the most
relevant population in which a specific and rapid diagnos-
tic test is needed (e.g., for inclusion in clinical trials), these
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including uncomplicated malaria, non-immune individuals
including travelers, and lower incidence environments,
where recently treated malaria may be less common.
In summary, the findings of this study indicate that a
three-band RDT incorporating both HPR2 and pLDH an-
tigens can improve diagnostic specificity for falciparum
malaria over a two-band RDT (HRP2 alone) in a sub-
Saharan African context, by excluding false positive HRP2
results due to recently treated infection. Added specificity
may be desirable when rapid identification of true cases is
required, as for screening patients for inclusion in clinical
trials. The three-band RDT has a positive predictive value
of 94% in this context.
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